European Biotech Acquisition Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $3,503,734 over the previous period. Total operating expenses were $2,817,944.
Profit Margin
| 2021 | 0 | 1.47M | |
|---|---|---|---|
| 2022 | 0 | 3.50M |
EBAC Income Statement (2021 – 2022)
| 2022 | 2021 | |
|---|---|---|
Revenue | ||
Revenue | 0 | 0 |
Cost of revenue | 0 | 0 |
Gross profit | 0 | 0 |
Operating exp. | ||
Research and development | 0 | 0 |
Selling and marketing | 0 | 0 |
Total operating expenses | 2.81M | 1.09M |
Operating income | -2.81M | -1.09M |
Other income (expenses), net | 3.16M | 2.57M |
Income before tax | 342.89K | 1.47M |
Income tax expense | -3.16M | 0 |
Net income | 3.50M | 1.47M |
Earnings per share | ||
Basic EPS | 0.27 | 0.43 |
Diluted EPS | 0.27 | 0.11 |
| Data source | Data source |